{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:43:24Z","timestamp":1761396204949,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s12185-022-03288-x","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T18:02:22Z","timestamp":1643133742000},"page":"906-912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hemophilic pseudotumor of the maxillary sinus in an inhibitor-positive patient with hemophilia A receiving emicizumab: a case report"],"prefix":"10.1007","volume":"115","author":[{"given":"Fuko","family":"Kawahara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1047-9428","authenticated-orcid":false,"given":"Rie","family":"Shirayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Oshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuji","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kusuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"key":"3288_CR1","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/S2352-3026(19)30054-7","volume":"6","author":"SW Pipe","year":"2019","unstructured":"Pipe SW, Shima M, Lehle M, Shapiro A, Chebon S, Fukutake K, et al. Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study. Lancet Haematol. 2019;6:e295-305.","journal-title":"Lancet Haematol"},{"key":"3288_CR2","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1182\/blood.2020009217","volume":"137","author":"MU Callaghan","year":"2021","unstructured":"Callaghan MU, Negrier C, Paz-Priel I, Chang T, Chebon S, Lehle M, et al. Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1\u20134 studies. Blood. 2021;137:2231\u201342.","journal-title":"Blood"},{"key":"3288_CR3","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1056\/NEJMoa1511769","volume":"374","author":"M Shima","year":"2016","unstructured":"Shima M, Hanabusa H, Taki M, Matsushita T, Sato T, Fukutake K, et al. Factor VIII mimetic function of humanized bispecific antibody in hemophilia A. N Engl J Med. 2016;374:2044\u201353.","journal-title":"N Engl J Med"},{"key":"3288_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2491\/jjsth.31.93","volume":"31","author":"T Tokugawa","year":"2020","unstructured":"Tokugawa T, Ishiguro Y, Ohira K, Okamoto K, Sakai M, Suzuki T, et al. Appendix edition: hemostatic treatment guidelines for hemophilia patients the use of Hemlibra\u00ae (Emicizumab). Japan J Thrombo Hemost. 2020;31:93\u2013104.","journal-title":"Japan J Thrombo Hemost"},{"key":"3288_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/ajh.2830450202","volume":"45","author":"M Magall\u00f3n","year":"1994","unstructured":"Magall\u00f3n M, Monteagudo J, Altisent C, Ib\u00e1\u00f1ez A, Rodr\u00edguez-P\u00e9rez A, Riba J, et al. Hemophilic pseudotumor: multicenter experience over a 25\u00a0year period. Am J Hematol. 1994;45:103\u20138.","journal-title":"Am J Hematol"},{"key":"3288_CR6","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1017\/S002221510014561X","volume":"113","author":"P Raj","year":"1999","unstructured":"Raj P, Wiide JT, Oliff J, Drake-Lee AB. Nasal haemophilic pseudotumour. J Laryngol Otol. 1999;113:924\u20137.","journal-title":"J Laryngol Otol"},{"key":"3288_CR7","first-page":"262","volume-title":"Treatment of hemophilia and coagulation disorders","author":"AJ Gunning","year":"1966","unstructured":"Gunning AJ. The surgery of hemophilic cysts. In: Biggs R, Macfarlane RG, editors. Treatment of hemophilia and coagulation disorders. Oxford: Blackwell; 1966. p. 262."},{"key":"3288_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1046\/j.1365-2516.2001.00566.x","volume":"7","author":"S Gupta","year":"2001","unstructured":"Gupta S, Mohapatra BB, Ghai S, Seith A, Kashyap R, Sharma R, et al. Haemophilic pseudotumour of the paranasal sinuses: management with radiotherapy and factor replacement therapy. Haemophilia. 2001;7:595\u20139.","journal-title":"Haemophilia"},{"key":"3288_CR9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1258\/0022215021910573","volume":"116","author":"DS Stevenson","year":"2002","unstructured":"Stevenson DS, Keast AT. An unusual cause of epistaxis: a haemophilic pseudotumour in a non-haemophiliac, araising in a paranasal sinus. J Laryngol Otol. 2002;116:294\u20135.","journal-title":"J Laryngol Otol"},{"key":"3288_CR10","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1097\/00005537-200410000-00016","volume":"114","author":"NP Steele","year":"2004","unstructured":"Steele NP, Myssiorek D, Zahtz GD, Diamond A. Pediatric hemophilic pseudotumor of the paranasal sinus. Laryngoscope. 2004;114:1761\u20133.","journal-title":"Laryngoscope"},{"key":"3288_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/1076029610366433","volume":"17","author":"F Xue","year":"2011","unstructured":"Xue F, Sun C, Sui T, Zhang L, Jiang L, Yang R. Hemophilic pseudotumor in Chinese patients: a retrospective single-centered analysis of 14 cases. Clin Appl Thromb Hemost. 2011;17:279\u201382.","journal-title":"Clin Appl Thromb Hemost"},{"key":"3288_CR12","doi-asserted-by":"publisher","first-page":"20150440","DOI":"10.1259\/dmfr.20150440","volume":"45","author":"AY Kwon","year":"2016","unstructured":"Kwon AY, Huh KH, Yi WJ, Symkhampha K, Heo MS, Lee SS, et al. Haemophilic pseudotumor in two parts of the maxilla: case report. Dento Maxillo Facial Radiol. 2016;45:20150440.","journal-title":"Dento Maxillo Facial Radiol"},{"key":"3288_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S1079-2104(05)80284-7","volume":"79","author":"SO de Sausa","year":"1995","unstructured":"de Sausa SO, de Piratininga J, Pinto J\u00fanior DS, de Ara\u00fajo N. Hemophilic pseudotumor of the jaws: report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:216\u20139.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"3288_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/ped.13197","volume":"59","author":"Y Ogata","year":"2017","unstructured":"Ogata Y, Monji M, Kai K, Matsuo M. Nasal hemophilic pseudotumor in a patient with mild hemophilia A and allergic rhinitis. Pediatr Int. 2017;59:237\u20139.","journal-title":"Pediatr Int"},{"key":"3288_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s13312-013-0071-7","volume":"50","author":"R Purkait","year":"2013","unstructured":"Purkait R, Mukherjee A, Nakar S, Bhadra R. Nasal hemophilic pseudotumor favorable response to radiotherapy. Indian Pediatr. 2013;50:334\u20135.","journal-title":"Indian Pediatr"},{"key":"3288_CR16","first-page":"7","volume":"1","author":"S D\u00edaz Loberto","year":"1998","unstructured":"D\u00edaz Loberto S, Tejero MTG, Ruiz Cobos A, Villasante C. Changing ventilator: an option to take into account in the treatment of persistent vomiting during nasal ventilation. Respiration. 1998;1:7\u201312.","journal-title":"Respiration"},{"key":"3288_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1055\/s-0040-1717114","volume":"121","author":"C Schmitt","year":"2021","unstructured":"Schmitt C, Adamkewicz JI, Xu J, Petry C, Catalani O, Young G, et al. Pharmacokinetics and pharmacodynamics of emicizumab in persons with hemophilia A with factor VIII inhibitors: HAVEN 1 study. Thromb Haemost. 2021;121:351\u201360.","journal-title":"Thromb Haemost"},{"key":"3288_CR18","first-page":"1","volume":"00","author":"M Kaneda","year":"2021","unstructured":"Kaneda M, Kawasaki R, Matsumoto N, Abe H, Tashiro Y, Inokuchi Y, et al. Detailed snalysis of anti-emicizumab antibosy decreasing drug efficacy, using plasma samples from a patient with hemophilia A. J Thromb Haemost. 2021;00:1\u20139.","journal-title":"J Thromb Haemost"},{"key":"3288_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/antib8040056","volume":"8","author":"VA Thomas","year":"2019","unstructured":"Thomas VA, Balthasar JP. Understanding inter-individual variability in monoclonal antibody disposition. Antibodies (Basel). 2019;8:56.","journal-title":"Antibodies (Basel)"},{"key":"3288_CR20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/bjh.16574","volume":"190","author":"S Furukawa","year":"2020","unstructured":"Furukawa S, Nogami K, Shimonishi N, Nakajima Y, Matsumoto T, Shima M. Prediction of the haemostatic effects of bypassing therapy using comprehensive coagulation assays in emicizumab prophylaxis-treated haemophilia A patients with inhibitors. Br J Haemost. 2020;190:727\u201335.","journal-title":"Br J Haemost"},{"key":"3288_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12185-019-02698-8","volume":"110","author":"K Yada","year":"2019","unstructured":"Yada K, Nogami K, Ogiwara K, Shida Y, Furukawa S, Yaoi H, et al. Global coagulation function assessed by rotational thromboelastometry predicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis. Int J Hematol. 2019;110:419\u201330.","journal-title":"Int J Hematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03288-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-022-03288-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03288-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T13:32:43Z","timestamp":1654090363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-022-03288-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3288"],"URL":"https:\/\/doi.org\/10.1007\/s12185-022-03288-x","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2022,1,25]]},"assertion":[{"value":"18 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"FK, RS, TI, KO, and KK have received research grant to the department of pediatrics from Chugai Pharmaceutical Co., Ltd. RS has received payment for lectures on speaker's bureau from Fujimoto Pharmaceutical Corp., Takeda Pharmaceutical Co., Ltd., and Chugai Pharmaceutical Co., Ltd. TI has received payment for lectures on speaker's bureau from Fujimoto Pharmaceutical Corp., Takeda Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Sanofi S.A., and Novo Nordisk A\/S. KO has received payment for lectures on speaker's bureau from Takeda Pharmaceutical Co., Ltd., Sanofi S.A., and Chugai Pharmaceutical Co., Ltd. TS has received payment for lectures on speaker's bureau from CSL Behring, Takeda Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Sanofi S.A., Bayer AG, Shire plc, Bioverativ Inc., and Nihon Pharmaceutical Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}